Effect of prior moderate exercise on postprandial metabolism in men with type 2 diabetes: Heterogeneity of responses
Abstract
Prior moderate exercise has been shown consistently to reduce postprandial triglyceride (TG) concentrations in non-diabetic adults, but its effects in men with type 2 diabetes are not known. This study aimed to determine the effect of moderate exercise on postprandial metabolism in men with type 2 diabetes. Ten middle-aged men with type 2 diabetes underwent two oral fat tolerance tests (blood taken fasting and for 8
h after a meal containing 80
g fat, 70
g carbohydrate) in random order. On the afternoon before one test, participants performed a 90-min treadmill walk (Exercise); no exercise was performed before the Control test. Exercise significantly reduced fasting glucose (Control: 9.08
±
0.75
mmol
l−1, Exercise: 8.40
±
0.72
mmol
l−1, p
=
0.033) and insulin (Control: 8.01
±
0.98
μU
ml−1, Exercise: 6.81
±
0.93
μU
ml−1, p
=
0.046) and increased fasting 3-hydroxybutyrate (Control: 87.1
±
19.2
μmol
l−1, Exercise: 134.3
±
28.4
μmol
l−1, p
=
0.011); reduced postprandial insulin by 11.0% (p
=
0.04) and increased postprandial 3-hydroxybutrate by 31.8% (p
=
0.03); but did not significantly change fasting or postprandial triglyceride or NEFA concentrations. However, the exercise-induced change in postprandial triglyceride concentration ranged from −32.3 to +28.3% and the exercise-induced change in fasting 3-hydroxybutyrate concentration (a marker of hepatic fatty acid oxidation) was highly correlated with the exercise-induced changes in fasting and postprandial triglyceride (r
=
0.68, p
=
0.03 for both).
Thus, inter-individual variation in propensity to increase hepatic fatty acid oxidation following exercise may account for the considerable heterogeneity in triglyceride responses to moderate exercise observed in men with type 2 diabetes.
Keywords: Exercise, Type 2 diabetes, Postprandial lipemia, Triglyceride, Ketogenesis, 3-Hydroxybutyrate
To access this article, please choose from the options below
PII: S0021-9150(06)00613-7
doi:10.1016/j.atherosclerosis.2006.10.007
© 2006 Elsevier Ireland Ltd. All rights reserved.
